181 results
Page 5 of 10
8-K
wo5ws62abyoc8b
11 Jan 21
Results of Operations and Financial Condition
12:00am
8-K
EX-1.1
s6h wthet2dbo0i
18 Dec 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
6:30am
424B5
v1zhf58rnlfz1c9d8
16 Dec 20
Prospectus supplement for primary offering
4:04pm
424B5
rrl8kxvou5 o20hp
14 Dec 20
Prospectus supplement for primary offering
5:21pm
S-3ASR
EX-4.3
jyv85eo7zuq
14 Dec 20
Automatic shelf registration
4:06pm
S-3ASR
xx4d9cz
14 Dec 20
Automatic shelf registration
4:06pm
S-3ASR
EX-23.1
iuc2l4kye30i0wfv l8
14 Dec 20
Automatic shelf registration
4:06pm
S-3ASR
EX-4.4
fi5oun53 qd91nd
14 Dec 20
Automatic shelf registration
4:06pm
8-K
EX-1.1
kiqtqv
16 Oct 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
6:58am
424B5
ate1o9
14 Oct 20
Prospectus supplement for primary offering
4:17pm
424B5
63p27fm6
13 Oct 20
Prospectus supplement for primary offering
5:24pm
8-K
4596gnhf
7 Oct 20
Results of Operations and Financial Condition
8:10am
8-K
2ygc96c
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
3z5v 4dw42n51d4ymx
1 Jul 20
Submission of Matters to a Vote of Security Holders
4:15pm
DEFA14A
0stiuyc4m0 fzisd02n
15 Jun 20
Additional proxy soliciting materials
4:16pm